CA Stock MarketDetailed Quotes

DTR DiagnosTear Technologies Inc

Watchlist
  • 0.510
  • +0.060+13.33%
15min DelayMarket Closed Jan 2 15:09 ET
29.98MMarket Cap-1.77P/E (TTM)

About DiagnosTear Technologies Inc Company

DiagnosTear Technologies Inc is an ophthalmic company developing and commercializing disruptive diagnostic solutions for better management of eye diseases. Its TeaRx technology is a diagnostic platform intended for rapid, Point-of-Care Testing (POCT) of ophthalmic pathologies through multi-parameter analysis of non-invasively collected tear fluid. The first CE-IVD and Israeli MoH-approved test based on the TeaRx platform is intended for diagnosis of Dry Eye Syndrome. This product is not FDA-cleared yet. Beyond DES, It is developing innovative tests based on the TeaRx platform for additional ophthalmic indications. Its pipeline includes TeaRx Red Eye; The first test of its kind for differential assessment of adenoviral conjunctivitis, Herpetic Keratitis and Allergic conjunctivitis.

Company Profile

SymbolDTR
Company NameDiagnosTear Technologies Inc
Founded2023
MarketCNQ
Fiscal Year Ends12-31
AddressManahem Plaut 10
CityRehovot
CountryIsrael
Phone+972 523408550

Company Executives

No Data

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.